ACTA NEUROPHARMACOLOGICA››2022,Vol. 12››Issue (2): 47-.DOI:10.3969/j.issn.2095-1396.2022.02.009

Previous ArticlesNext Articles

Research Progress in Migraine Combined with Patent Oval Foramen

ZHAO Bo,YU Ai-mei,ZOU Yu-an

  1. 1. Graduate School of Hebei North University,Zhangjiakou,075000,China 2. Department of Neurology,The First Affiliated Hospital of Hebei North University,Zhangjiakou,075000,China
  • Online:2022-04-26Published:2022-04-26

Abstract:

Migraine is a disabling chronic neurovascular disease characterized by severe hemiplegic headache attacks. Migraine attacks are intensely painful,and when they occur, most activities of daily living and work can no longer be carried out normally,productivity is significantly reduced,and healthcare-related costs are significantly increased. Migraine ranks third among the most common diseases in the world(after dental caries and tension headaches), and ranks eighth in disability due to disease,with high morbidity,high disease burden,and wide impact. Significant adverse effects on the patient's quality of life.

Key words:migraine,patent oval foramen,right to left shunt,calcitonin gene related peptid,substance-P,platelet

CLC Number:

Baidu
map